You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 1, January 1, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA

Relationship Between Hormone Replacement Therapy, Socioeconomic Status, and Coronary Heart Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their review of observational studies of postmenopausal hormone replacement therapy (HRT), Dr Nelson and colleagues1 incorrectly claim that our findings from the Nurses' Health Study (NHS)2-3 failed to control for education or socioeconomic status (SES) in analyzing postmenopausal HRT use and risk of coronary heart disease (CHD). Because all NHS participants are registered nurses, with nearly identical education, we adjusted for education using stratification.2-3 The authors also incorrectly state that studies controlling for alcohol intake or physical activity failed to observe a lower risk of CHD among HRT users. We recently reported a relative risk (RR) of CHD of 0.64 (95% confidence interval, 0.54-0.76) for current vs never HRT users, after adjustment for alcohol and physical activity (in addition to other covariates).2

Nelson et al cited 4 studies that controlled for SES and yielded nonsignificant results for risk of CHD. However, these studies do not support . . . [Full Text of this Article]


RELATED ARTICLES

Relationship Between Hormone Replacement Therapy, Socioeconomic Status, and Coronary Heart Disease
Linda L. Humphrey, Heidi D. Nelson, Benjamin K. S. Chan, Peggy Nygren, Janet Allan, and Steve Teutsch
JAMA. 2003;289(1):45.
EXTRACT | FULL TEXT  

Postmenopausal Hormone Replacement Therapy: Scientific Review
Heidi D. Nelson, Linda L. Humphrey, Peggy Nygren, Steven M. Teutsch, and Janet D. Allan
JAMA. 2002;288(7):872-881.
ABSTRACT | FULL TEXT  

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Writing Group for the Women's Health Initiative Investigators
JAMA. 2002;288(3):321-333.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Socioeconomic Position and Hormone Replacement Therapy Use: Explaining the Discrepancy in Evidence From Observational and Randomized Controlled Trials
Lawlor et al.
Am. J. Public Health 2004;94:2149-2154.
ABSTRACT | FULL TEXT  

Commentary: The hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?
Lawlor et al.
Int J Epidemiol 2004;33:464-467.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.